Zebra Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,707
Closed -$122K 70
2022
Q3
$122K Buy
12,707
+137
+1% +$1.32K 0.46% 66
2022
Q2
$91K Sell
12,570
-369
-3% -$2.67K 0.27% 90
2022
Q1
$167K Sell
12,939
-3,807
-23% -$49.1K 0.38% 100
2021
Q4
$267K Sell
16,746
-6,172
-27% -$98.4K 0.43% 85
2021
Q3
$368K Buy
+22,918
New +$368K 0.45% 81